Dysplastic naevi with moderate to severe histological dysplasia: A risk factor for melanoma

British Journal of Dermatology

Volumn 155, Issue 5, 2006, Pages 988-993

  Shors, A R ^a   Kim, S ^a   White, E ^b   Argenyi, Z ^a   Barnhill, R L ^c   Duray, P ^d   Erickson, L ^e   Guitart, J ^f   Horenstein, M G ^g   Lowe, L ^h   Messina, J ⁱ   Rabkin, M S ^j   Schmidt, B ^k   Shea, C R ^l   Trotter, M J ^m   Piepkorn, M W ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d VA BOSTON HEALTHCARE SYSTEM   (United States)

^e MAYO CLINIC   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Dermatology Group   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF SOUTH FLORIDA   (United States)

^j Rabkin Dermatopathology Laboratory   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l UNIVERSITY OF CHICAGO   (United States)

^m UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

Atypical naevi; Case control; Dysplastic naevi; Melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DYSPLASIA; DYSPLASTIC NEVUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; SKIN EXAMINATION;

ADULT; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; OBSERVER VARIATION; PIGMENTATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

EID: 33749853332     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07466.x     Document Type: Article

References (27)

1. Tripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol 2002; 46:674-82.
2. Ackerman AB. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology 1988; 13:241-56.
3. Roush GC, Nordlund JJ, Forget B et al. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med 1988; 17:273-9.
4. Tucker MA, Halpern A, Holly EA et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997; 277:1439-44.
5. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459-68.
6. Halpern AC, Guerry D IV, Elder DE et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol 1991; 127:995-9.
7. Garbe C, Buttner P, Weiss J et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102:695-9.
8. Bataille V, Bishop JA, Sasieni P et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73:1605-11.
9. Annessi G, Cattaruzza MS, Abeni D et al. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol 2001; 45:77-85.
10. NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992; 268:1314-19.
11. Elder DE, Green MH, Guerry D IV et al. The dysplastic nevus syndrome: our definition. Am J Dermatopathol 1982; 4:455-60.
12. Piepkorn MW, Barnhill RL, Cannon-Albright LA et al. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol 1994; 30:707-14.
13. Grob JJ, Gouvernet J, Aymar D et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and super-ficial spreading melanoma. Cancer 1990; 66:387-95.
14. Roush GC, Barnhill R. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX. Br J Cancer 1991; 64:943-7.
15. Ahmed I, Piepkorn MW, Rabkin MS et al. Histopathologic characteristics of dysplastic nevi. Limited association of conventional histologic criteria with melanoma risk group. J Am Acad Dermatol 1990; 22:727-33.
16. Barnhill RL. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics. Clin Plast Surg 2000; 27:331-60, viii.
17. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70:213-20.
18. Arumi-Uria M, McNutt NS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003; 16:764-71.
19. Black WC, Hunt WC. Histologic correlations with the clinical diagnosis of dysplastic nevus. Am J Surg Pathol 1990; 14:44-52.
20. Bergman W, Ruiter DJ, Scheffer E, van Volten WA. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis. Cancer 1988; 61:1660-6.
21. Klein LJ, Barr RJ. Histologic atypia in clinically benign nevi. A prospective study. J Am Acad Dermatol 1990; 22:275-82.
22. Schmidt B, Weinberg DS, Hollister K, Barnhill RL. Analysis of melanocytic lesions by DNA image cytometry. Cancer 1994; 73:2971-7.
23. Piepkorn M, Meyer LJ, Goldgar D et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989; 20:407-15.
24. Duncan LM, Berwick M, Bruijn JA et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol 1993; 100:S318-21.
25. Clemente C, Cochran AJ, Elder DE et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol 1991; 22:313-19.
26. de Wit PE, van't Hof-Grootenboer B, Ruiter DJ et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer 1993; 29A:831-9.
27. Weinstock MA, Barnhill RL, Rhodes AR, Brodsky GL. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol 1997; 133:953-8.